Calmodulin-stimulated plasma membrane (Ca2+ + Mg2+)-ATPase: inhibition by calcium channel entry blockers.

Calcium channel entry blockers representing different structural classes were studied for their effects on human erythrocyte basal and calmodulin-stimulated (Ca2+ + Mg2+)-ATPase. Effects on the activity of (Mg2+)-ATPase and (Na+ + K+)-ATPase were also assessed. Of the four Ca2+ entry blockers tested, only verapamil and diltiazem specifically inhibited the calmodulin-stimulated (Ca2+ + Mg2+)-ATPase activity, the basal enzyme activity being unaltered by these drugs. Other membrane-associated ATPases were not affected. Calmodulin concentration effect curves showed the inhibition by verapamil (10(-3) M) and diltiazem (10(-3) M) to be non-competitive. This concentration inhibited the calmodulin-dependent increment (5.1 nM calmodulin) of the ATPase activity by 35 and 36% respectively. Similarly, both drugs inhibited the Ca2+-activation process of calmodulin-stimulated activity in a non-competitive manner, decreasing Vmax by 23 and 17% respectively. Basal (Ca2+ + Mg2+)-ATPase activity was not affected by verapamil or diltiazem at any calcium concentration. In contrast, cinnarizine non-specifically inhibited all four membrane ATPases including calmodulin-stimulated (Ca2+ + Mg2+)-ATPase activity at concentrations above 3 X 10(-6) M. Nifedipine was without effect on any of the four membrane ATPases. From this we conclude that certain calcium channel entry blockers can inhibit calmodulin-regulated plasma membrane Ca2+-pump ATPase. Therefore, this identifies an additional functional low affinity receptor in the plasma membrane for some of the calcium channel entry blockers.

[1]  B. Weiss,et al.  Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. , 1979, The Journal of pharmacology and experimental therapeutics.

[2]  O. Scharff,et al.  Effect of trifluoperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte Ca2+-ATPase. , 1984, Biochimica et biophysica acta.

[3]  P. Epstein,et al.  Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin. , 1982, Biochemical and biophysical research communications.

[4]  B. Roufogalis,et al.  Phenothiazine antagonism of calmodulin: a structurally-nonspecific interaction. , 1981, Biochemical and biophysical research communications.

[5]  A. Fleckenstein.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. , 1977, Annual review of pharmacology and toxicology.

[6]  Y. Matsuda,et al.  Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker. , 1984, Biochemical and biophysical research communications.

[7]  M. Spedding.  Calcium antagonist subgroups , 1985 .

[8]  B. Weiss,et al.  Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins. , 1978, Biochimica et biophysica acta.

[9]  H. Belle.  R 24 571: A potent inhibitor of calmodulin-activated enzymes , 1981 .

[10]  G. Zernig,et al.  Ca2+ antagonist receptor sites on human red blood cell membranes. , 1985, European journal of pharmacology.

[11]  H. Schatzmann.  The red cell calcium pump. , 1983, Annual review of physiology.

[12]  A. Wüthrich,et al.  Compound 48/80 is a selective and powerful inhibitor of calmodulin-regulated functions. , 1983, Biochimica et biophysica acta.

[13]  K. Gietzen,et al.  Inhibition of human erythrocyte Ca++-transport ATPase by phenothiazines and butyrophenones. , 1980, Biochemical and biophysical research communications.

[14]  C. Lugnier,et al.  Bepridil and flunarizine as calmodulin inhibitors. , 1984, European journal of pharmacology.

[15]  D. Storm,et al.  Calcium-induced exposure of a hydrophobic surface on calmodulin. , 1980, Biochemistry.

[16]  J. Johnson,et al.  A fluorescent calmodulin that reports the binding of hydrophobic inhibitory ligands. , 1983, The Biochemical journal.

[17]  F. Vincenzi,et al.  A semi-automated method for the determination of multiple membrane ATPase activities. , 1980, Journal of pharmacological methods.